The combination of heparin and aspirin is widely regarded as 'standard therapy' to increase rates of live birth in patients with recurrent pregnancy loss and positive antiphospholipid antibodies. However, this recommendation is based largely on expert opinion. Does a meta-analysis of randomized controlled trials support the practice?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mak, A., Cheung, M. W., Cheak, A. A. & Ho, R. C. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology (Oxford) 49, 281–288 (2010).
Levine, J. S., Branch, D. W. & Rauch, J. The antiphospholipid syndrome. N. Engl. J. Med. 346, 752–763 (2002).
Empson, M., Lassere, M., Craig, J. & Scott, J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database of Systematic Reviews. Issue 2. Art. No.: CD002859. doi:10.1002/14651858.CD002859.pub2 (2005).
American College of Obstetricians and Gynecologists. ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). Int. J. Gynaecol. Obstet. 78, 179–190 (2002).
Miyakis, S. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4, 295–306 (2006).
Bates, S. M., Greer, I. A., Pabinger, I., Sofaer, S. & Hirsh, J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (Suppl.), S844–S886 (2008).
Girardi, G., Redecha, P. & Salmon, J. E. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat. Med. 10, 1222–1226 (2004).
White, N. J., McGready, R. M. & Nosten, F. H. New medicines for tropical diseases in pregnancy: catch-22. PLoS Med. 5, e133 (2008).
Chervenak, F. A. & McCullough, L. B. Ethics of research in perinatal medicine. Semin. Perinatol. 33, 391–396 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Gelber, S., Salmon, J. Effectiveness of treatments for pregnant women with APS. Nat Rev Rheumatol 6, 187–189 (2010). https://doi.org/10.1038/nrrheum.2010.42
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2010.42